Please wait...
About This Project
The etiological agent for Chagas' disease is the protozoan parasite Trypanosoma cruzi, which affects 6 - 7 million people primarily in Latin America. The chronic stage of infection causes cardiomyopathy and the enlargement of other organs resulting in disease burden and death. There is an urgent need to replace the clinical therapeutics (benznidazole & nifurtimox) and this proposal focuses on a compound screen to observe a hit expansion with the target T. cruzi glucokinase.
More Lab Notes From This Project
![Blast off!](https://d1sg0ksu7mr16v.cloudfront.net/admin_uploads/emails/April/EFF_rocket.gif)
Browse Other Projects on Experiment
Related Projects
Developing a low-cost, rapid diagnostic for urogenital Schistosomiasis infection
We are developing a frugal diagnostic for urogenital schistosomiasis, a neglected tropical disease that...
The Health Justice Project: Using digital stories to address health disparities as a social justice issue
The purpose of this project is to examine the link between racial and social injustice based on one's minority...
Finding a Cure for Batten Disease
In March of this year, both of our daughters, Charlotte and Gwenyth, were diagnosed with Late Infantile...